Drug Search Results
More Filters [+]

Betrixaban

Alternative Names: betrixaban, prt054021, bevyxxa
Latest Update: 2024-05-01
Latest Update Note: Clinical Trial Update

Product Description

Betrixaban is used to prevent venous thromboembolism (VTE) in hospitalized patients at risk for blood clots because of the loss or decreased ability to move around or due to other factors. Betrixaban is a factor Xa inhibitor, an anticoagulant. It works by decreasing the clotting ability of the blood and helps prevent harmful clots from forming in the blood vessels. (Sourced from: https://www.mayoclinic.org/drugs-supplements/betrixaban-oral-route/description/drg-20406393)

Mechanisms of Action: FXa Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Bangladesh | European Medicines Agency

Approved Indications: Embolism | Thromboembolism | Venous Thromboembolism

Known Adverse Events: Injuries/wounds Unspecified

Company: AstraZeneca
Company Location: CAMBRIDGE X0 CB2 0AA
Company CEO: Pascal Soriot
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Betrixaban

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Venous Thromboembolism

Phase 2: Thromboembolism|Atrial Flutter|Stroke|Healthy Volunteers|Atrial Fibrillation|Injuries/wounds Unspecified

Phase 1: Healthy Volunteers|Tic Disorders|Kidney Diseases|Venous Thrombosis|Venous Thromboembolism|Neuromyelitis Optica|Embolism and Thrombosis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Protocol 16-021 – Pediatric PK

P1

Terminated

Neuromyelitis Optica|Venous Thromboembolism|Embolism and Thrombosis|Venous Thrombosis|Tic Disorders

2020-08-05

NCT03346083

P1

Terminated

Venous Thromboembolism

2019-10-08

NCT03397888

P1

Completed

Healthy Volunteers

2018-01-16

22%

NCT03330457

P2

Terminated

Injuries/wounds Unspecified|Healthy Volunteers

2016-02-22

Recent News Events